摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 4-[(3,4-dichlorophenyl)amino]-5,8-dihydropyrido[4',3':4,5]furo[2,3-d]pyrimidine-7(6H)-carboxylate | 1130156-14-7

中文名称
——
中文别名
——
英文名称
ethyl 4-[(3,4-dichlorophenyl)amino]-5,8-dihydropyrido[4',3':4,5]furo[2,3-d]pyrimidine-7(6H)-carboxylate
英文别名
Ethyl 4-[(3,4-dichlorophenyl)amino]-5,8-dihydropyrido[4',3':4,5]furo[2,3-d]pyrimidine-7(6H)carboxylate;ethyl 3-(3,4-dichloroanilino)-8-oxa-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraene-11-carboxylate
ethyl 4-[(3,4-dichlorophenyl)amino]-5,8-dihydropyrido[4',3':4,5]furo[2,3-d]pyrimidine-7(6H)-carboxylate化学式
CAS
1130156-14-7
化学式
C18H16Cl2N4O3
mdl
——
分子量
407.256
InChiKey
SFSTUSHHPSTNMC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    568.5±50.0 °C(predicted)
  • 密度:
    1.482±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    80.5
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION
    申请人:BAYER HEALTHCARE AG
    公开号:WO2009033581A1
    公开(公告)日:2009-03-19
    This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly cancer.
    这项发明涉及新颖化合物及其制备方法,治疗疾病的方法,特别是癌症,包括给予这些化合物,以及制备用于治疗或预防疾病,特别是癌症的药物组合物的方法。
  • SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
    申请人:Schirok Hartmut
    公开号:US20110021493A1
    公开(公告)日:2011-01-27
    This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly cancer.
    本发明涉及新型化合物及其制备方法,涉及使用该化合物治疗疾病的方法,特别是癌症,以及制备用于治疗或预防疾病,特别是癌症的药物组合物的方法。
  • US8524722B2
    申请人:——
    公开号:US8524722B2
    公开(公告)日:2013-09-03
  • Substituted tricyclic compounds and methods of use thereof
    申请人:Schirok Hartmut
    公开号:US08524722B2
    公开(公告)日:2013-09-03
    This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly cancer.
    本发明涉及新型化合物及其制备方法,涉及用于治疗疾病的方法,尤其是癌症,包括给予该化合物的方法,以及制备用于治疗或预防疾病,尤其是癌症的药物组合物的方法。
查看更多

同类化合物

呋喃并[2,3-d]嘧啶-4(1H)-酮 呋喃并[2,3-d]嘧啶-2(3H)-酮 呋喃并[2,3-d]嘧啶 6-苯基呋喃并[2,3-D]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4(3H)-酮 6-(4-甲氧基苯基)呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲氧基苯基)-5-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲基苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(4-氯苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(3-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 5-甲基呋喃并[2,3-d]嘧啶-4-胺 5-溴呋喃并[2,3-D]嘧啶-4-胺 5-氯甲基呋喃并[2,3-d]嘧啶-2,4-二胺 5,6-二甲基呋喃[2,3-d]嘧啶-4-胺 4-氯呋喃[2,3-D]嘧啶 4-氯-6-甲基-呋喃并[2,3-d]嘧啶 4-氨基呋喃并[2,3-D]嘧啶 4,6-二甲基呋喃并[2,3-d]嘧啶 4,6-二甲基呋喃并[2,3-D]嘧啶-2-胺 3-(2-脱氧-beta-D-赤式-呋喃戊糖基)-6-甲基呋喃并[2,3-d]嘧啶-2(3H)-酮 2-甲基硫代呋喃并[2,3-d]嘧啶-6-甲醇 2,4-二氯呋喃并[2,3-d]嘧啶 2,4-二氯-5-甲基呋喃并[2,3-d]嘧啶 5,6-dimethylfuro<2,3-d>pyrimidine-4-carbonitrile 6-(3-aminophenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine 6-(3-aminophenyl)-N-(3-chlorophenyl)furo[2,3-d]pyrimidin-4-amine 2-{[6-(3-aminophenyl)furo[2,3-d]pyrimidin-4-yl]amino}-4-chlorophenol 6-(3-aminophenyl)-N-(4-chloro-2-fluorophenyl)-furo[2,3-d]pyrimidin-4-amine 6-(3-aminophenyl)-N-(3,5-dichlorophenyl)furo[2,3-d]pyrimidin-4-amine 5-{[6-(3-aminophenyl)furo[2,3-d]pyrimidin-4-yl]amino}-2-methylphenol 1-(6-[4-(2-dimethylamino-ethoxy)-phenyl]-5-methyl-2-thiophene-2-yl-furo[2,3-d]pyrimidin-4-ylamino)-3-methyl-pyrrole-2,5-dione (R)-4-(4-((1-phenylethyl)amino)furo[2,3-d]pyrimidin-6-yl)benzonitrile pyrrolidine-1-carboxylic [6-(4-methoxy-phenyl)-furo[2,3-d]pyrimidin-4-yl]-amide N3-[(1-benzyl-1,2,3-triazol-4-yl)methyl]-6-(hex-1-yl)furo[2,3-d]pyrimidine-2-one N3-{[1-(4-chlorophenyl)-1,2,3-triazol-4-yl]methyl}-6-(hex-1-yl)-5-(oct-1-yn-1-yl)furo[2,3-d]pyrimidine-2-one N3-{[1-(2-fluorophenyl)-1,2,3-triazol-4-yl]methyl}-(6-hex-1-yl)furo[2,3-d]pyrimidine-2-one 6-pentyl-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)aminoethoxy]ethanol 6-(4-n-pentylphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)amino]butan-1-ol 4-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)amino]butan-1-ol 4-chloro-5,6-dimethylfuro[2,3-d]pyrimidine 3-butyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 3-dodecyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 6-(hexylsulfanylmethyl)-3-octylfuro[2,3-d]pyrimidin-2(3H)-one 3-decyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 6-decyl-2-propoxyfuro[2,3-d]pyrimidine